Match each patient's clinical presentation with the most appropriate contraceptive method based on efficacy, symptom management, and medical eligibility criteria.
- 32-year-old woman with heavy menstrual bleeding and anemia, desiring highly effective, long-acting contraception.Levonorgestrel-releasing intrauterine device
- 29-year-old woman with a history of breast cancer currently in remission, desiring long-acting contraception.Copper intrauterine device
- 22-year-old woman requesting an oral emergency contraceptive 96 hours (4 days) after unprotected intercourse.Ulipristal acetate
- 27-year-old woman with a history of migraines with aura who desires a daily oral contraceptive.Progestin-only pill
Answer
Heavy bleeding matches with Levonorgestrel IUD. Breast cancer history matches with Copper IUD. Emergency contraception at 96 hours matches with Ulipristal acetate. Migraine with aura matches with the Progestin-only pill.
Each correct pairing directly applies the Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO) Medical Eligibility Criteria (MEC) for contraceptive use, ensuring patients receive methods that address their specific therapeutic needs (like heavy bleeding) while avoiding methods that pose severe health risks (like hormones in breast cancer or estrogen in migraine with aura).
Step-by-Step Solution
Key Concept
Applying WHO Medical Eligibility Criteria (MEC) to select safe and appropriate contraceptive methods based on patient comorbidities.